Matrix metalloproteinase-9 expression in asthma: Effect of asthma severity, allergen challenge, and inhaled corticosteroids

Chest

Volumn 122, Issue 5, 2002, Pages 1543-1552

  Mattos, Waldo ^a   Lim, Sam ^a   Russell, Richard ^a   Jatakanon, Anon ^a   Chung, K Fan ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergen challenge; Asthma; Corticosteroid; Matrix metalloproteinase; Matrix metalloproteinase 9; Tissue inhibitors of matrix metalloproteinase

Indexed keywords

ALLERGEN; BUDESONIDE; CORTICOSTEROID; GELATINASE B; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ALLERGY TEST; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 0036435871     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.5.1543     Document Type: Article

References (38)

1. Laitinen LA, Heino M, Laitinen A, et al. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 131:599-606
2. Jeffery PK, Wardlaw AJ, Nelson FC, et al. Bronchial biopsies in asthma: An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140:1745-1753
3. Roche WR, Beasley R, Williams JH, et al. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1:520-524
4. Redington AE, Sime PJ, Howarth PH, et al. Fibroblasts and the extracellular matrix in asthma. In: Marone G, Austen KF, Holgate ST, et al, eds. Asthma and Allergic Diseases: Physiology, Immunopharmacology, and Treatment. London, UK: Academic Press, 1998; 443-467
5. Xia M, Leppert D, Hauser SL, et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol; 1996; 156:160-167
6. Leppert D, Waubant E, Galardy R, et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995; 154:4379-4389
7. Delclaux C, Delacourt C, D'Ortho MP, et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14:288-295
8. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 1994; 370:555-557
9. Kayagaki N, Kawasaki A, Ebata T, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182:1777-1783
10. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992; 7:120-125
11. O'Connor CM, FitzGerald MX. Matrix metalloproteinases and lung disease. Thorax 1994; 49:602-609
12. Massova I, Kotra LP, Fridman R, et al. Matrix metalloproteinases: Structures, evolution, and diversification. FASEB J 1998; 12:1075-1095
13. Murphy G, Nguyen Q, Cockett MI, et al. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 1994; 269:6632-6636
14. Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kd gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: Purification and activation of the precursor and enzymic properties. J Biol Chem 1992; 25:21712-21719
15. Ohno I, Ohtani H, Nitta Y, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16:212-219
16. Mautino G, Oliver N, Chanez P, et al. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997; 17:583-591
17. Warner JA, Julius P, Luttmann W, et al. Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge. Int Arch Allergy Immunol 1997; 113:318-320
18. Vignola AM, Riccobono L, Mirabella A, et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158:1945-1950
19. Jeffery PK, Godfrey RW, Adelroth E, et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992; 145:890-899
20. Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150:17-22
21. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyper-responsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999; 159:1043-1051
22. Hoshino M, Takahashi M, Takai Y, et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999; 104:356-363
23. John M, Lim S, Seybold J, et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998; 157:256-562
24. Zhang Y, McCluskey K, Fujii K, et al. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-α, granulocyte-macrophage-CSF, and IL-1-β through prostaglandin-dependent and independent mechanisms. J Immunol 1998; 161:3071-3076
25. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
26. Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticosteroids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542-548
27. Di Girolamo N, Tedla N, Lloyd A, et al. Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. Eur J Immunol 1998; 28:1773-1784
28. Roberts CR, Okazawa M, Wiggs B, et al. Airway wall thickening. In: Barnes PJ, Grunstein MM, Leff AR, et al, eds. Asthma. 1st Ed. Philadelphia, PA: Lippincott-Raven Publishers, 1997; 925-935
29. Lemjabbar H, Gosset P, Lamblin C, et al. Contribution of 92 kd gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999; 159:1298-1307
30. Yao PM, Maitre B, Delacourt C, et al. Divergent regulation of 92 kd gelatinase and TIMP-1 by HBECs in response to IL-1 and TNF-α. Am J Physiol 1997; 273:866-874
31. Johnatty RN, Taub DD, Reeder SP, et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997; 158:2327-2333
32. Okada S, Kita H, Georga TJ, et al. Migration of eosinophils through basement membrane components in vitro: Role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997; 17:519-528
33. Saren P, Welgus HG, Kovanen PT. TNF-α and IL-1β selectively induce expression of 92-kd gelatinase by human macrophages. J Immunol 1996; 157:4159-4165
34. Corcoran ML, Stetler SW, Brown PD, et al. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kd type IV collagenase/gelatinase production by human monocytes. J Biol Chem 1992; 267:515-519
35. Mertz PM, DeWitt DL, Stetler SW, et al. Interleukin 10 suppression of monocyte prostaglandin H synthase-2: Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 1994; 269:21322-21329
36. Mautino G, Henriquet C, Jaffuel D, et al. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. Am J Respir Crit Care Med 1999; 160:324-330
37. Bosse M, Chakir J, Rouabhia M, et al. Serum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999; 159:596-602
38. Dahlen B, Shute J, Howarth P. Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax 1999; 54:590-596